Alumis (ALMS) Interest & Investment Income (2023 - 2024)
Alumis (ALMS) reported Interest & Investment Income of $2.0 million for Q2 2024, up 116.54% year-over-year from $913000.0 in Q3 2023, and up 116.54% quarter-over-quarter from $913000.0 in Q2 2023.
Alumis (ALMS) Interest & Investment Income (2023 - 2024) Analysis & Trends
Alumis (ALMS) has 2 years of Interest & Investment Income data on file, last reported at $2.0 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Alumis | 1.99 Bn | 1.90 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 1.98 Mn |
| Jun 30, 2023 | 913,000.00 |